Sabrina Kuttruff is a seasoned biotech executive with over 15 years of experience in corporate finance and research and development initiatives, particularly in the dynamic fields of cancer immunotherapy and anti-viral therapies. As the Group CFO and a member of the Executive Board at AiCuris...
Sabrina Kuttruff is a seasoned biotech executive with over 15 years of experience in corporate finance and research and development initiatives, particularly in the dynamic fields of cancer immunotherapy and anti-viral therapies. As the Group CFO and a member of the Executive Board at AiCuris Anti-infective Cures AG, she plays a pivotal role in steering the company’s financial strategy and operational excellence. Her responsibilities encompass a broad spectrum of critical functions, including Finance, Human Resources, IT, Investor and Public Relations, and Legal affairs, ensuring that AiCuris operates with a robust governance framework while fostering innovation.
Sabrina's expertise in corporate development and strategic planning is instrumental in aligning AiCuris's long-term goals with its operational capabilities. She collaborates closely with the CEO and Board of Directors to formulate and execute strategies that drive growth and enhance shareholder value. Her leadership extends to managing AiCuris subsidiaries, where she oversees financial performance and operational efficiency, ensuring that each entity aligns with the overarching corporate vision.
Key projects under her stewardship include navigating complex mergers and acquisitions (M&A) to expand the company’s portfolio, as well as securing grants that fuel R&D initiatives. Sabrina’s proficiency in risk management and personalized medicine positions AiCuris at the forefront of innovation in the biotech sector. Her commitment to advancing clinical trials and developing cutting-edge therapies underscores her passion for improving patient outcomes, making her a vital asset to AiCuris and the broader healthcare community.
